Sonobird: a pivotal trial in recurrent glioblastoma
SONOBIRD is a randomized, open-label, multicentric, two-arm pivotal trial comparing treatment with SonoCloud-9 combined with carboplatin versus standard of care lomustine or temozolomide in patients undergoing planned resection for first recurrence of glioblastoma.
